Clinical study on Fuzheng Tongluo Formula in the treatment of idiopathic pulmonary fibrosis
- Conditions
- Idiopathic pulmonary fibrosis
- Registration Number
- ITMCTR2000003803
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of TCM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the IPF diagnostic criteria of Western medicine;
2. Patients who meet the TCM diagnostic criteria of kidney deficiency and collateral stasis type;
3. Patients aged 50-85 years, both male and female;
4. Patients with good compliance;
5. Patients who voluntarily participate in the experiment and sign informed consent.
1. Acute exacerbation or fulminant patients or late critical patients;
2. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system and mental illness;
3. Patients with other acute diseases such as infection, fever and bleeding;
4. Pregnant or lactating women;
5. Patients who are known to be allergic to test drug ingredients;
6. Patients who participated in other clinical studies in recent 3 months;
7. Patients who are not willing to receive trial treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HRCT;TCM syndrome integral and single main symptom integral;
- Secondary Outcome Measures
Name Time Method Serum cytokines;Blood gas analysis;modified medical research council;St. George's respiratory questionnaire;six minutes walk distance;Pulmonary function;